INTELLIA THERAPEUTICS INC. revenue breakdown overview

INTELLIA THERAPEUTICS INC. revenue for the last year amounted to 32.87 M EUR, the most of which — 32.87 M EUR — came from its highest performing source at the moment, Genome Editing-based Therapies, the year earlier bringing 48.70 M EUR. The greatest contribution to the revenue figure was made by United States — last year it brought INTELLIA THERAPEUTICS INC. 32.87 M EUR, and the year before that — 48.70 M EUR.